Geoff Davison, CEO, Bionow
Chair: Steve Bagshaw, UK Vaccines Task Force
Speakers
David Hunt, Head of Influenza Vaccine Operations, AstraZeneca
Peter Coleman, Chief Executive, Cobra Biologics (A Charles River Company)
Andy Jones, Medicines Manufacturing Industrial Strategy Challenge Fund Director, Innovate UK
Amanda Halford, Vice President Commercial US, Canada, Latin America, Europe and Service, Cytiva
Lucy Foley, Business Unit Director, CPI
Chair: Mike Tobyn, Scientific Director, Bristol Myers Squibb
Speakers
Patrick Wray, Principal Scientist, Drug Product Development, Bristol Myers Squibb
Nobel Vale, Principal Scientist, Drug Product Development, Bristol Myers Squibb
James Young, Technical Lead, AstraZeneca
John Mack, Head of Business Unit, Perceptive Engineering
Chair: Steve Richmond, Head of Sterile Manufacture, AstraZeneca
Speakers
Gareth Jenkins, Science & Technology Director, Arcinova (A Quotient Science business)
Natasha Van Rutten, Product Development Director, Catalent Pharma Solutions
Tim Eaton, Steriles Manufacturing Specialist, AstraZeneca
Kris Holmes, General Manager, Parker Hannifin
Chair: Neil Wetherall, Managing Director, Factory Talk
Speakers
Donal Bourke, Manager - New Business Development & Digital Enterprise Solutions, Yokogawa
Karol Dabrowski, Chief Executive Officer, Eviview
Claire Holt, Business & Partnerships Consultant, Hosokawa Micron Limited
Michael Killilea, Associate Director - Operations, Alexion Pharmaceuticals
Chair: Richard Ryrie, Project/Tech Transfer Manager, Elanco
Speakers
Peter Simpson, Chief Scientific Officer, Medicines Discovery Catapult
Philip Carvill, HealthTec Cluster Manager, Science and Technology Facilities Council
Hannah Randles, Healthcare and Life Sciences Champion, LCR Growth Platform and Innovation Agency
Ben Dolman, Chief Executive Officer, Holiferm
Chair: Linda Randall, Associate Vice President, Biologics Development, Pharmaron
Speakers
Alan Dickson, Professor of Biotechnology, University of Manchester
Mimoun Azzouz, Director of the Gene Therapy Innovation & Manufacturing Centre and Chair of Translational Neuroscience, University of Sheffield
Jen Vanderhoven, Director, National Horizons Centre
Laura Bennett, Skills Consultant on behalf of CGT Catapult
Andy Jones joined UKRI in Q4 2018, following more than 30 years’ working in development and manufacturing in the Pharmaceutical industry. He has held senior positions in Science and Technology leadership, Site Management and Project and Portfolio Management, giving him a broad overview of the development of new medicines and healthcare technologies.
Andy has been responsible for the development of Chemistry, Manufacturing and Control (CMC) aspects of several multibillion-dollar products in the fields of Oncology, Neuroscience and Cardiovascular & Metabolic Disease.
Latterly while leading Pharmaceutical Innovation and Manufacturing Science & Technology in AstraZeneca he has driven advances in Modelling & Simulation, Digital Therapeutics and Advanced Manufacturing technologies.
Andy has a PhD in Organic Chemistry from the University of Wales Institute of Science & Technology and joined the pharmaceutical industry following a period of postdoctoral research at the University of Colorado.
Robert Docherty did his degree and PhD. at Strathclyde University and joined ICI/Zeneca in 1988 where he worked on the structure and crystallization of dyes, pigments, biocides, electrophotographic agents, agrochemicals and pharmaceuticals.
He joined Pfizer in 1999 as Head of Material Sciences. He retired from his role as Strategic Lead for Digital Design at Pfizer in December 2020. He holds a visiting professorship at Leeds University and is a Fellow of the Royal Society of Chemistry.
His research interests have focused on the structural and simulation aspects of the assembly of molecules to crystals, crystals to particles and particles to products in order to support a community vision towards an unprecedented digital perspective of the journey from molecule to medicine.
Throughout his career he has been fortunate to work at the industrial/academic interface with numerous partners to help create and guide a range of research projects and has published over 75 journal papers and book chapters.
Registration will open shortly. For any further queries please contact info@bionow.co.uk
Pre-recorded company showcases will provide participants with the opportunity to introduce their company, promote and generate interest in specific products or services, attract potential partners and collaborations and most of all grow your network!
These digital exhibition packages have been introduced to provide additional benefit and value to delegates, who can create a captivating video presentation and increase engagement with fellow delegates.
Each Company Showcase Package will consist of:-
Please click HERE to view the Company Showcase Guidelines